cyc 202 has been researched along with juglone in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (juglone) | Trials (juglone) | Recent Studies (post-2010) (juglone) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 359 | 0 | 212 |
| Protein | Taxonomy | cyc 202 (IC50) | juglone (IC50) |
|---|---|---|---|
| 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ | Yersinia pseudotuberculosis YPIII | 5.35 | |
| Aurora kinase A | Homo sapiens (human) | 0.05 | |
| DNA topoisomerase 1 | Homo sapiens (human) | 8.26 | |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 1 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 3.035 | |
| M-phase inducer phosphatase 2 | Homo sapiens (human) | 1.98 | |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | 5.9 | |
| Aurora kinase B | Homo sapiens (human) | 0.62 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huttunen, HJ; Kysenius, K; Nykänen, NP; Sakha, P; Tammela, P | 1 |
1 other study(ies) available for cyc 202 and juglone
| Article | Year |
|---|---|
γ-Aminobutyric acid type A (GABAA) receptor activation modulates tau phosphorylation.
Topics: Alzheimer Disease; Animals; Cell Line, Tumor; Cyclin-Dependent Kinase 5; Cytoskeleton; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Marine Toxins; Mice; Naphthoquinones; Nerve Degeneration; Neuroblastoma; NIMA-Interacting Peptidylprolyl Isomerase; Oxazoles; Peptidylprolyl Isomerase; Phosphorylation; Protein Kinase Inhibitors; Protein Phosphatase 2; Purines; Rats; Receptors, GABA-A; Roscovitine; tau Proteins; Tauopathies | 2012 |